Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920433 Inner Mongolia Grand Pharmaceutical Co Ltd BJSE:920433
70 GF Score
Price ¥4.94
GF Value ¥3.89
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Inner Mongolia Grand Pharmaceutical Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Inner Mongolia Grand Pharmaceutical Co Valuation Rank Related Terms

BJSE:920433
70GF Score
Inner Mongolia Grand Pharmaceutical Co Ltd BJSE:920433
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) Overvalued in 2026?

Based on GuruFocus' analysis, Inner Mongolia Grand Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥4.94 is trading 27% above its estimated GF Value™ of ¥3.89. GuruFocus considers Inner Mongolia Grand Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for BJSE:920433:

  • Valuation Rank:
  • GF Value™: ¥3.89 vs. price of ¥4.94 (27% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the BJSE:920433 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Inner Mongolia Grand Pharmaceutical Co Business Description

Address Wuwei Road, 2nd Floor, Administration Building, Ruyi Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010010
Inner Mongolia Grand Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating the development of Mongolian medicine resources. It engages in the research and development, production, and sales of specialty medicines and general health products. The company's main business is the research and development, production of Chinese patent medicines (including ethnic medicines) and chemical preparations, and sales.
70GF Score

Get the complete analysis for BJSE:920433

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.94
Price
¥3.89
GF Value